Natural Absorbable Sutures Market Size, Share, Key Developments, and Forecast 2032
Natural Absorbable Sutures Market Size, Share, Key Developments, and Forecast 2032
The natural absorbable sutures market involves surgical sutures made from naturally derived materials—most commonly surgical gut (catgut) produced from purified collagen of animal intestines—that are designed to be absorbed by the body over time, eliminating the need for suture removal. These sutures provide reliable wound support during the healing process and are commonly used in procedures involving internal tissues, ligatures, and obstetric or gynecological surgeries. Market growth is driven by the rising number of surgical procedures worldwide, the preference for absorbable sutures to reduce post-operative care, and ongoing demand in both developed and emerging healthcare markets. Hospitals and ambulatory surgical centers are the primary end users, with applications spanning general surgery, dental procedures, and soft-tissue repairs.
The global natural absorbable sutures market size was valued at USD 921.8 million in 2024 and is projected to grow from USD 959.2 million in 2025 to USD 1,498.4 million by 2032, exhibiting a CAGR of 6.6% during the forecast period. North America dominated the natural absorbable sutures market with a 36.16% share in 2024, driven by rising surgical procedures, advanced healthcare infrastructure, and growing preference for biocompatible wound closure solutions.
The competitive landscape includes a mix of global giants and specialized regional manufacturers. Notable names in the market include:
Johnson & Johnson Services, Inc. (U.S.)
DemeTECH Corporation (U.S.)
Medtronic (Ireland)
Dolphin Sutures (India)
Lotus Surgicals Pvt Ltd (India)
Suture Planet (India)
Medico (China)
Healthium Medtech Limited (India)
ORION SUTURES INDIA PVT. LTD. (India)
Unisur Lifecare (India)
Dynek Pty Ltd (Australia)
A major growth driver is the rising geriatric population, which increases the prevalence of chronic diseases and surgical procedures such as orthopedic, cardiovascular, and general surgeries. Another key driver is the surging volume of surgeries globally, including cardiac, cosmetic, general, and orthopedic operations, fueling demand for natural absorbable sutures. Furthermore, healthcare infrastructure expansion in developing economies and government support for new hospitals and specialty clinics also contribute to market growth.
One main challenge is the shift toward advanced wound-closure alternatives, such as surgical staplers and tissue adhesives, which often offer faster application and may reduce dependency on sutures. Also, natural absorbable sutures (often of animal origin, e.g. catgut) are more susceptible to infection, inflammatory responses, and hypersensitivity reactions, which raises safety concerns. Regulatory hurdles and stringent requirements from global health authorities also slow development, as extensive clinical validation is required, increasing time and cost burdens for manufacturers.
The natural absorbable sutures market is segmented along multiple axes:
Material: plain gut, chromic gut, collagen sutures, and others.
Application: general surgeries, cardiovascular surgeries, gynecological surgeries, orthopedic surgeries, and others.
End-User: hospitals & ambulatory surgical centers (ASCs), specialty clinics, and others. The hospitals & ASCs segment is expected to dominate, driven by high surgical volumes.
Region / Geography: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
Within applications, general surgery is expected to maintain a moderate CAGR, with growing use in procedures like cholecystectomy, appendectomy, and hysterectomy. Cardiology is also expected to emerge as a faster growth application area, as cardiac surgeries increase globally. On the end-user side, hospitals & ASCs will continue to lead adoption, while specialty clinics and other settings will see moderate growth.
Explore the full research report with detailed insights and TOC:https://www.fortunebusinessinsights.com/natural-absorbable-sutures-market-113842
In 2024, North America dominated the natural absorbable sutures market with a share of 36.16 %, accounting for about USD 333.4 million. Europe is the second major region, supported by high surgical volumes, established healthcare systems, and rising chronic disease burden. The Asia Pacific region is projected to post the highest growth rate during the forecast period, driven by medical tourism, rising healthcare spending, increasing surgical procedures, and large population bases in India, China, and Japan. Latin America and Middle East & Africa are expected to grow at more moderate rates due to lower healthcare expenditure and infrastructure, though affordability of natural absorbable sutures offers tailwinds in these markets.
The outlook for the natural absorbable sutures market is positive. Given the forecasted growth to USD 1,498.4 million by 2032 (CAGR 6.6 %), players in this space have ample opportunities to expand. Innovation in material science—for example, sutures with more predictable absorption, enhanced tensile strength, coatings to reduce infection, and improved handling—will play a pivotal role in differentiating offerings. Expansion in emerging markets and increased surgical infrastructure investment will open new growth avenues. Strategic initiatives by companies—such as international expansion, alliances with hospitals and clinics, and participation in global medical events—will help raise brand visibility and adoption. As an illustration, ORION SUTURES INDIA’s presence at Arab Health 2025 in Dubai underscores how manufacturers are leveraging global platforms to showcase product innovation and reach new markets.
The natural absorbable sutures market is positioned for steady growth over the coming decade, fueled by demographic shifts, rising surgical interventions, and evolving preference for bio-compatible wound closure solutions. Key players spanning the U.S., Europe, Asia, and Australia are competing on product innovation, regulatory compliance, and geographic reach. While challenges such as competition from advanced closure technologies and infection risk remain, opportunities beckon in emerging markets and development of next-generation suture materials. With robust forecasts and expanding demand horizons, the market presents compelling potential for manufacturers, investors, and healthcare providers alike.
About Us:
Fortune Business Insights provides expert corporate analysis and accurate data, enabling businesses of all sizes to make timely decisions. We offer customized solutions tailored to each client’s needs, helping them address unique challenges. Our goal is to empower clients with holistic market intelligence and offer granular insights into the market they operate in.
Contact us:
Fortune Business Insights™ Pvt.
Phone: USA: +1 833 909 2966 (Toll-Free),
United Kingdom: +44 808 502 0280 (Toll-Free),
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com